冠状动脉CT在心血管疾病评估与预防保健中应用价值的医疗政策声明:来自心血管CT学会卫生政策工作组
心血管CT学会联合拉什大学医学中心及多方代表于2016年11月在芝加哥召开峰会,评估心血管影像面临的障碍,探讨如何在维持或改善结局与质量的同时提升效率;本文详述峰会进程、既往障碍、现状与潜在解决方案。
要点
- 峰会汇集支付方、提供方和患者视角,为各方声音提供平台并推动建设性对话。
- 文章详述峰会进程,回顾既往障碍、现状及在医疗格局变化中的潜在解决方案。
核心结论
- 心血管影像在心脏病风险患者和患者诊疗中处于核心地位,峰会旨在评估障碍并探讨提升效率同时维持或改善结局与质量的潜在解决方案。
研究设计与样本
- 心血管CT学会与拉什大学医学中心合作,联合政府机构、区域支付方和行业医疗专家于2016年11月在伊利诺伊州芝加哥召开峰会,纳入支付方、提供方和患者视角。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The rising cost of healthcare is prompting numerous policy and advocacy discussions regarding strategies for constraining growth and creating a more efficient and effective healthcare system. Cardiovascular imaging is central to the care of patients at risk of, and living with, heart disease. Estimates are that utilization of cardiovascular imaging exceeds 20 million studies per year. The Society of Cardiovascular CT (SCCT), alongside Rush University Medical Center, and in collaboration with government agencies, regional payers, and industry healthcare experts met in November 2016 in Chicago, IL to evaluate obstacles and hurdles facing the cardiovascular imaging community and how they can contribute to efficacy while maintaining or even improving outcomes and quality. The summit incorporated inputs from payers, providers, and patients' perspectives, providing a platform for all voices to be heard, allowing for a constructive dialogue with potential solutions moving forward. This article outlines the proceedings from the summit, with a detailed review of past hurdles, current status, and potential solutions as we move forward in an ever-changing healthcare landscape.
引用
- Slim AM, Jerome S, Blankstein R, et al. Healthcare Policy Statement on the Utility of Coronary Computed Tomography for Evaluation of Cardiovascular Conditions and Preventive Healthcare: From the Health Policy Working Group of the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2017. PMID: 28867495. doi:10.1016/j.jcct.2017.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。